Until every
disease is cured.
We are developing agentic AI to create new medicines faster than ever before.
The First AI Agent in Pharma
AgentCures has agency. It actively navigates the drug discovery process from start to end, making decisions, suggesting experiments, generating insights, and even autonomously authoring regulatory applications. What is an AI agent?

Pharma as Code
Every experiment, every drug property, and every regulatory document is treated like software—structured and version-controlled. AgentCures autonomously commits its work to Git, ensuring complete provenance and transparency. What is version control and Git?
AI-Human Collaboration
AI can’t do everything, yet. That’s why AgentCures was built to seamlessly collaborate with human experts. Scientists and engineers work alongside AI as true partners, using the same version control system to co-develop the future of medicine.

A System That Evolves
AgentCures isn’t static. It constantly updates itself, writes its own research, and even authors regulatory filings and news articles. AgentCures even updates this very website. This is what we mean by AI-first—everything AI can do, AI does.
Clinical blueprints on demand
The pipeline translates patient segmentation and PK/PD projections into draft trial protocols. Teams can review the study design, projected outcomes, and underlying assumptions before the first patient is enrolled.
From Concept to Cure, at AI Speed
Our philosophy is simple: If it can be automated, it is. Everything from insilico analysis, assay design, clinical trial design, even authoring papers about its research—including IND applications—AgentCures handles it all. The future of medicine isn’t slow. It’s relentless, autonomous, and unstoppable—until every human disease is cured. That is what we are building.
AgentCures Was Created by JJ Ben-Joseph

JJ Ben-Joseph is a distinguished technology executive and venture capitalist specializing in the convergence of biology, artificial intelligence, and security. He has made significant contributions through published research, strategic venture investments, innovative product development, and founding pioneering companies. Recognized as a thought leader and experienced practitioner, he was honored as an "Emerging Leader in Biosecurity" by Johns Hopkins University. Learn more on his LinkedIn profile.